PECAM1 and cancer: As shown in the CD45/CD31 multiplex fluorescence immunohistochemistry image (Fig. 7a), abundant microvascularity and immune cell infiltration have been present in the untreated tumors, providing a rational basis for the enrichment of LRT nanomedicine in tumor tissue and cancer immunotherapy.